Market closedNon-fractional
Avid Bioservices/CDMO
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Avid Bioservices
Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. Its business is organized into one reportable operating segment which is contract manufacturing and development services segment. Its services include clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. The company also provides a variety of process development services including cell line development, upstream and downstream development and optimization, analytical method development, testing and characterization.
Ticker
CDMO
Sector
Healthcare
Trading on
NASDAQ
Industry
Biotechnology
Headquarters
Tustin, United States
Employees
-
Website
www.avidbio.com
Avid Bioservices Metrics
BasicAdvanced
$656M
Market cap
-
P/E ratio
-$2.23
EPS
1.36
Beta
-
Dividend rate
Price and volume
Market cap
$656M
Beta
1.36
Financial strength
Current ratio
1.474
Quick ratio
1.013
Long term debt to equity
336.727
Total debt to equity
341.333
Interest coverage (TTM)
-4.31%
Management effectiveness
Return on assets (TTM)
-2.96%
Return on equity (TTM)
-112.58%
Valuation
Price to revenue (TTM)
4.662
Price to book
10.7
Price to tangible book (TTM)
10.7
Price to free cash flow (TTM)
-31.277
Growth
Revenue change (TTM)
-6.27%
Earnings per share change (TTM)
-55,026.11%
3-year revenue growth (CAGR)
13.43%
3-year earnings per share growth (CAGR)
239.50%
What the Analysts think about Avid Bioservices
Analyst Ratings
Majority rating from 5 analysts.
Avid Bioservices Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$34M
-46.43%
Net income
-$6M
-48.28%
Profit margin
-17.75%
-3.43%
Avid Bioservices Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
-
-$0.03
-$0.15
-$0.09
-
Expected
-
-$0.03
-$0.06
-$0.05
-$0.04
Surprise
-
9.09%
140.00%
71.43%
-
Avid Bioservices News
AllArticlesVideos
Avid Bioservices, Inc. (CDMO) Q4 2024 Earnings Call Transcript
Seeking Alpha·3 weeks ago
Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024
GlobeNewsWire·3 weeks ago
Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024
GlobeNewsWire·4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Avid Bioservices stock?
Avid Bioservices (CDMO) has a market cap of $656M as of July 27, 2024.
What is the P/E ratio for Avid Bioservices stock?
The price to earnings (P/E) ratio for Avid Bioservices (CDMO) stock is 0 as of July 27, 2024.
Does Avid Bioservices stock pay dividends?
No, Avid Bioservices (CDMO) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next Avid Bioservices dividend payment date?
Avid Bioservices (CDMO) stock does not pay dividends to its shareholders.
What is the beta indicator for Avid Bioservices?
Avid Bioservices (CDMO) has a beta rating of 1.36. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Avid Bioservices stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.